MedTrace Logo

Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)

NCT01669603 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 789

Last updated 2017-04-25

Study results available
· View outcomes & findings →

Summary

The study is designed to assess the effect of ingestion of a probiotic on innate and adaptive host responses to rhinovirus infection.

Conditions

  • Common Cold

Interventions

DIETARY_SUPPLEMENT

Bifidobacterium lactis Bl-04

The study product will be a 2\*109 cfus of probiotic Bifidobacterium lactis Bl-04 mixed with 1g of sucrose as a carrier.

DIETARY_SUPPLEMENT

Placebo

Placebo will be 1g of sucrose that has identical appearance, smell, and taste with the study product.

BIOLOGICAL

Rhinovirus

rhinovirus for experimental challenge

Sponsors & Collaborators

  • DuPont Nutrition and Health

    collaborator INDUSTRY

  • University of Virginia

    lead OTHER

Principal Investigators

  • Ronald Turner, MD · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01669603 on ClinicalTrials.gov